|Mr. Mark C. Throdahl||Pres, CEO & Director||604.5k||N/A||1951|
|Mr. Fred L. Hite||CFO, Principal Financial & Accounting Officer, COO and Director||532.21k||N/A||1968|
|Mr. Daniel J. Gerritzen||VP of Legal & HR, Gen. Counsel and Sec.||426k||N/A||1970|
|Mr. David R. Bailey||Pres||444.36k||N/A||1979|
|Mr. Gregory A. Odle||Exec. VP of Commercialization||444.91k||N/A||1970|
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, and QuickPack. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2007 and is headquartered in Warsaw, Indiana.
OrthoPediatrics Corp.’s ISS Governance QualityScore as of December 6, 2019 is 9. The pillar scores are Audit: 2; Board: 10; Shareholder Rights: 8; Compensation: 7.